AprilBio Co.,Ltd. (KOSDAQ:397030)

South Korea flag South Korea · Delayed Price · Currency is KRW
54,900
-200 (-0.36%)
At close: Dec 30, 2025
258.59%
Market Cap1.28T
Revenue (ttm)8.97B
Net Income (ttm)-877.63M
Shares Out23.21M
EPS (ttm)-39.00
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume851,698
Average Volume1,451,700
Open54,300
Previous Close55,100
Day's Range52,900 - 56,900
52-Week Range11,980 - 56,900
Beta1.61
RSI72.44
Earnings Daten/a

About AprilBio

AprilBio Co., Ltd. develops long-acting type biobetter and antibody biologics. The company develops products based on its long-acting protein medicine platform technology. It is developing various products for use in the treatment of rare diseases, cancer, male infertility, autoimmune and inflammatory diseases. The company was founded in 2013 and is headquartered in Chuncheon-si, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2013
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 397030
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.